Page last updated: 2024-11-01

olprinone and Anasarca

olprinone has been researched along with Anasarca in 2 studies

olprinone: RN refers to HCl; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Treatment with olprinone reduced the numbers of polymorphonuclears in the BAL fluid, decreased the formation of most oxidation markers in the lungs, reduced lung edema and prevented a decrease in TAS in the lung homogenate compared to non-treated animals."1.38Selective phosphodiesterase 3 inhibitor olprinone attenuates meconium-induced oxidative lung injury. ( Calkovska, A; Drgova, A; Mokra, D; Pullmann, R, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iguchi, K1
Hatano, E1
Yamanaka, K1
Sato, M1
Yamamoto, G1
Kasai, Y1
Okamoto, T1
Okuno, M1
Taura, K1
Fukumoto, K1
Ueno, K1
Uemoto, S1
Mokra, D1
Drgova, A1
Pullmann, R1
Calkovska, A1

Other Studies

2 other studies available for olprinone and Anasarca

ArticleYear
Hepatoprotective effect by pretreatment with olprinone in a swine partial hepatectomy model.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2014, Volume: 20, Issue:7

    Topics: Animals; Bilirubin; Biopsy; Edema; Endothelial Cells; Enzyme Inhibitors; Female; Hemodynamics; Hepat

2014
Selective phosphodiesterase 3 inhibitor olprinone attenuates meconium-induced oxidative lung injury.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bronchoalveolar Lavage Fluid; Disease Models, Anima

2012